- Home
- CDXS vs CIA Comparison
CDXS vs CIA Comparison
Compare CDXS & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- CIA
- Stock Information
- Founded
- CDXS 2002
- CIA 1969
- Country
- CDXS United States
- CIA United States
- Employees
- CDXS N/A
- CIA N/A
- Industry
- CDXS Major Chemicals
- CIA Life Insurance
- Sector
- CDXS Industrials
- CIA Finance
- Exchange
- CDXS Nasdaq
- CIA Nasdaq
- Market Cap
- CDXS 230.3M
- CIA 220.6M
- IPO Year
- CDXS 2010
- CIA N/A
- Fundamental
- Price
- CDXS $2.11
- CIA $4.36
- Analyst Decision
- CDXS Buy
- CIA
- Analyst Count
- CDXS 2
- CIA 0
- Target Price
- CDXS $11.00
- CIA N/A
- AVG Volume (30 Days)
- CDXS 1.1M
- CIA 128.5K
- Earning Date
- CDXS 05-01-2025
- CIA 05-06-2025
- Dividend Yield
- CDXS N/A
- CIA N/A
- EPS Growth
- CDXS N/A
- CIA N/A
- EPS
- CDXS N/A
- CIA 0.29
- Revenue
- CDXS $59,345,000.00
- CIA $245,001,000.00
- Revenue This Year
- CDXS $12.62
- CIA $5.58
- Revenue Next Year
- CDXS $22.11
- CIA $5.06
- P/E Ratio
- CDXS N/A
- CIA $15.21
- Revenue Growth
- CDXS N/A
- CIA 1.79
- 52 Week Low
- CDXS $1.90
- CIA $1.95
- 52 Week High
- CDXS $6.08
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- CDXS 35.96
- CIA 48.37
- Support Level
- CDXS $1.91
- CIA $4.17
- Resistance Level
- CDXS $2.47
- CIA $4.39
- Average True Range (ATR)
- CDXS 0.21
- CIA 0.41
- MACD
- CDXS 0.02
- CIA 0.02
- Stochastic Oscillator
- CDXS 23.86
- CIA 74.11
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.